Zhejiang Jingxin Pharmaceutical Co (SZSE:002020) Change In Receivables : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Jingxin Pharmaceutical Co Change In Receivables?

Zhejiang Jingxin Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Zhejiang Jingxin Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Zhejiang Jingxin Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2024 was ¥-250 Mil. It means Zhejiang Jingxin Pharmaceutical Co's Accounts Receivable increased by ¥250 Mil from Dec. 2023 to Dec. 2024 .

Zhejiang Jingxin Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2025 was ¥757 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Zhejiang Jingxin Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 72.24.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Zhejiang Jingxin Pharmaceutical Co's liquidation value for the three months ended in Mar. 2025 was ¥-584 Mil.

Zhejiang Jingxin Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Zhejiang Jingxin Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jingxin Pharmaceutical Co Change In Receivables Chart

Zhejiang Jingxin Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

34.44

-208.58

-250.89

-93.48

-249.65

Zhejiang Jingxin Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Zhejiang Jingxin Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Zhejiang Jingxin Pharmaceutical Co (SZSE:002020) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Zhejiang Jingxin Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	756.846	/	956.069	*	91
=	72.24

2. In Ben Graham's calculation of liquidation value, Zhejiang Jingxin Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Zhejiang Jingxin Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	698.434	-	2262.918	+	0.75 * 756.846	+	0.5 * 824.775
=	-584

Zhejiang Jingxin Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Zhejiang Jingxin Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Jingxin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jingxin Pharmaceutical Co Ltd (SZSE:002020) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No.800 Xinchang East Road, Yulin subdistrict, Zhejiang Province, Xinchang, CHN, 312500

Website

http://www.jingxinpharm.com

Zhejiang Jingxin Pharmaceutical Co Ltd is an integrated pharmaceuticals enterprise that focuses on manufacturing, R&D, and marketing. It offers finished dosage forms which include tablets, capsules, and injections in the areas of antilipemic, antidiabetic, cholesterolemia, luoroquinolones, cephalosporin, gastrointestinal promotion, anti-inflammatory analgesic, and antibiotics; APIs, and Chinese herbal drugs. The products are sold to overseas markets such as South-east of Asia, South Asia, Latin America and Europe.

Executives

Wang Neng Neng	Director
Chen Shao Bi	Executives
Wang Guang Qiang	Supervisors
Lv Gang	Director
Zhou Lin	Executives
Yu Yi Ping	Supervisors
Chen Mei Li	Directors, executives
Zhang Li Wa	Directors, executives
Wu Zheng Jie	Director

Zhejiang Jingxin Pharmaceutical Co Headlines

No Headlines